Surgery in castlemans disease: A systematic review of 404 published cases

Annals of Surgery

Volumn 255, Issue 4, 2012, Pages 677-684

  Talat, Nadia ^a   Belgaumkar, Ajay P ^a   Schulte, Klaus Martin ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; HUMAN; IMMUNOTHERAPY; LYMPH NODE DISSECTION; LYMPHADENECTOMY; PHYSICIAN ASSISTANT; PRIORITY JOURNAL; REVIEW; SURGEON; SYSTEMATIC REVIEW; MORTALITY; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME;

GIANT LYMPH NODE HYPERPLASIA; HUMANS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84858708447     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318249dcdc     Document Type: Review

References (32)

1. Castleman B, Towne VW. Case records of the Massachusetts GeneralHospital: weekly clinicopathological exercises-founded by Richard C. Cabot. N Engl J Med. 1954;251:396-400.
2. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9:822-30.
3. Schulte KM, Talat N. Castleman's disease-a two compartment model of HHV8 infection. Nature Rev Clin Oncol. 2010;7:533-543.
4. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670-683.
5. Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009;16:236-246.
6. Oksenhendler E. HIV-associated multicentric Castleman disease. Curr Opin HIV AIDS. 2009;4:16-21.
7. Hengge UR, Ruzicka T, Tyring SK, et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis. 2002;2:344-352. (Pubitemid 34595974)
8. Guihot A, Couderc LJ, Rivaud E, et al. Thoracic radiographic and CT findings of multicentric Castleman disease in HIV-infected patients. J Thorac Imaging. 2007;22:207-211. (Pubitemid 46868299)
9. Hillier JC, Shaw P, Miller RF, et al. Imaging features of multicentric Castleman's disease in HIV infection. Clin Radiol. 2004;59:596-601. (Pubitemid 38950074)
10. Quint LE. Imaging of anterior mediastinal masses. Cancer Imaging. 2007;7(Spec No. A):S56-S62. (Pubitemid 350130853)
11. Teh HS, LinMB, Tan AS, et al. Retroperitoneal Castleman's disease in the perinephric space-imaging appearance: a case report and a review of the literature. Ann Acad Med Singapore. 2000;29:773-776. (Pubitemid 33710679)
12. Chaulin B, Pontais C, Laurent F, et al. Pancreatic Castleman disease: CT findings. Abdom Imaging. 1994;19:160-161. (Pubitemid 24090568)
13. Alberti MA, Martinez-Ýelamos S, Fernandez A, et al. 18F-FDG PET/CT in the evaluation of POEMS syndrome. Eur J Radiol. 2009;76:180-182.
14. Barker R, Kazmi F, Stebbing J, et al. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease. Eur J Nucl Med Mol Imaging. 2009;36:648-652.
15. Reddy MP, Graham MM. FDG positron emission tomographic imaging of thoracic Castleman's disease. Clin Nucl Med. 2003;28:325-326. (Pubitemid 38281957)
16. Theate I,Michaux L, Squifflet JP, et al. Human herpesvirus 8 and Epstein-Barr virus-related monotypic large B-cell lymphoproliferative disorder coexisting with mixed variant of Castleman's disease in a lymph node of a renal transplant recipient. Clin Transplant. 2003;17:451-454. (Pubitemid 37236119)
17. Sotrel A, Castellano-Sanchez AA, Prusmack C, et al. Castleman's disease in a child presenting with a partly mineralized solitary meningeal mass. Pediatr Neurosurg. 2003;38:232-237. (Pubitemid 36438763)
18. Caselli E, Padovani D, Di Carlo R, et al. Parotid localized Castleman's disease andHHV-8 infection: a case report. EurArchOtorhinolaryngol. 2008;265:377-380. (Pubitemid 351178530)
19. Hsi ED. Castleman Disease. Hematopathology. Philadelphia, PA: Churchill Livingstone Elsevier; 2007.
20. McClain KL, Natkunam Y, Swerdlow SH. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program. 2004;283-296.
21. Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol. 2005;56:155-167. (Pubitemid 41278654)
22. Parker A, Bowles K, Bradley JA, et al. Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients-BCSH and BTS Guidelines. Br J Haematol. 2010;149:693-705.
23. Dogan M, Dogan L, Ozdemir F, et al. Fifty-one Kaposi sarcoma patients. Clin Transl Oncol. 2010;12:629-633.
24. Bragg DG, Chor PJ, Murray KA, et al. Lymphoproliferative disorders of the lung: histopathology, clinical manifestations, and imaging features. AJR Am J Roentgenol. 1994;163:273-281. (Pubitemid 24242503)
25. Larroche C, Cacoub P, Soulier J, et al. Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol. 2002;69:119-126. (Pubitemid 34111164)
26. Martino G, Cariati S, Tintisona O, et al. Atypical lymphoproliferative disorders: Castleman's disease. Case report and review of the literature. Tumori. 2004;90:352-355. (Pubitemid 38981288)
27. Roca B. Castleman's disease. A review. AIDS Rev. 2009;11:3-7.
28. Zarate-Osorno A, Medeiros LJ, Danon AD, et al. Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases. Arch Pathol Lab Med. 1994;118:270-274. (Pubitemid 24093653)
29. Casper C, Krantz EM, Corey L, et al. Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis. 2008;198:23-30. (Pubitemid 351920285)
30. Casper C, Nichols WG, Huang ML, et al. Remission of HHV-8 and HIVassociated multicentric Castleman disease with ganciclovir treatment. Blood. 2004;103:1632-1634. (Pubitemid 38268952)
31. Bower M. How I treat HIV-associated multicentric Castleman disease. Blood. 2010;116:4415-4421.
32. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005;129: 3-17. (Pubitemid 40524047)